JP Stock MarketDetailed Quotes

7774 Japan Tissue Engineering

Watchlist
  • 737
  • +82+12.52%
20min DelayMarket Closed Apr 30 15:30 JST
29.93BMarket Cap208.78P/E (Static)

About Japan Tissue Engineering Company

Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Company Profile

Symbol7774
Company NameJapan Tissue Engineering
Founded1999-02-01
MarketTSE Growth
Fiscal Year Ends03-31
Address6-209-1 Miyakitadori Gamagori
Zip Code443-0022
Phone0533-66-2020

Company Executives

  • Name
  • Position
  • Salary
  • Ken-ichiro Hata
  • Representative Director President and Chief Executive Officer
  • --
  • Toshihiro Osuka
  • Director and Senior Managing Executive Officer
  • --
  • Yasuo Kitajima
  • Director
  • --
  • Toshiyuki Masai
  • Director
  • --
  • Takayuki Nakano
  • Director
  • --
  • Hirotsugu Bigashiyama
  • Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More